In this study, we found an onco-miRNA role for miR-130b in bladder cancer, and we revealed a potential scenario regarding its regulation, namely, that it sustained the activation of NF-κB signaling by decreasing the expression of the NF-κB inhibitor CYLD. The gene discussed is NFKB1; the disease is urinary bladder carcinoma.